|
|
|
|
|
 |
|
|
| |
 |
CME ACTIVITY |
 |
|
| Type 2 Diabetes Management in the 21st Century: The Role of Incretin-Based Therapies |
| Including proceedings from the American Diabetes Association's 65th Annual Scientific Sessions held in San Diego, California |
Activity Date: December 2005
Activity Info: Volume 5, (10E)
|
|
| |
|
|
|
|
Supported by an educational grant from |
| Amylin Pharmaceuticals, Inc and Eli Lilly and Company |
|
|
| |
|
|
|
|
|
|
|
|
|
|